During this phase, the heart is adapting to the stress and functioning normally, while the pathology slowly develops and does not produce symptoms serious enough for the patient to see a doctor. Understanding this silent phase and knowing how to recognise this disease at an early stage is what allows us to diagnose it on time.
Key Takeaways
What the Silent Stage of Heart Failure Actually Means
The American College of Cardiology and the American Heart Association have devised a methodology for categorising heart failure into stages from Stage A to Stage D. Stage A entails identifying subjects with a higher likelihood of getting heart failure and who do not yet have any heart-related deformities or abnormalities.
Stage B is where symptoms start slowly edging in. Even though these patients present with heart changes like deteriorated left ventricular function or hypertrophy of the left ventricle, they do not yet experience any heart failure symptoms.
By the time we are dealing with Stage B, the heart has mastered the compensatory function, interlacing its functioning with the increased heart rate, remodelling the ventricles, and turning on neurohormonal systems. Some of the changes that proved to be working wonders, but in the long run, they will only accelerate the process of heart muscle decline.
Why the Early Signs Are So Easy to Miss
Moving from Stage B to Stage C, when the manifestations of the disease become apparent, occurs gradually, and the early signs and symptoms lack specificity. They lend themselves more readily to self-justification and rationalisation rather than investigation:
Fatigue is explained by a busy lifestyle or poor sleep rather than deficient cardiac output.
Reduced exercise tolerance is rationalised as being out of shape rather than an early indication of hemodynamic impairment.
Some breathlessness while climbing stairs is put down to weight or fitness rather than increasing pulmonary pressure.
Some ankle swelling noticed in the evening is thought of as a normal consequence of prolonged standing.
Occasional short episodes of mild breathlessness at night resolve upon sitting up and are dismissed as caused by sleeping position.
Any of these factors taken alone is indeed non-specific. It is the combination of them, particularly in a person with pre-existing risk factors, that should lead to thorough assessment.
Who Is at Highest Risk of Silent Heart Failure
There are several factors that improve the chances of silent structural heart disease having been present:
A past myocardial infarction, even one that was hard to detect but shown on ECG.
Long-lasting poorly controlled hypertension leading to hypertensive heart disease.
Type 2 diabetes, which is a cause of diabetic cardiomyopathy.
Valve disease, most commonly aortic stenosis and mitral regurgitation.
Atrial fibrillation with rapid ventricular responses leading to tachycardia-related cardiomyopathy.
Long history of heavy alcohol consumption.
History of family non-ischemic cardiomyopathy.
How Early Heart Failure Is Diagnosed
Echocardiography is considered the best diagnostic method. It provides direct indications of changes in heart contraction, movement of its walls, and chamber size, as well as the heart's function during filling.
If the ejection fraction is less than 40%, the diagnosis of heart failure can be made in relation to heart failure with decreased fraction, which is the best-studied type of heart failure with treatment established.
Blood tests such as BNP or NT-proBNP measure the degree of stress in the walls of the heart and can also indicate whether a patient has asymptomatic heart disease. The ECG, chest X-ray, and cardiac MRI supplement the diagnosis in some cases.
Treatment That Changes the Trajectory
Starting treatment earlier in heart failure results in improved outcomes when compared to delaying treatment until major clinical decline. The neuroendocrine system that is activated due to structural heart disease causes further myocardial injury if it is not controlled.
Sacubitril/valsartan is a dual treatment that prevents angiotensin receptor blockade with valsartan and inhibits neprilysin, which is inhibited by sacubitril. Inhibition of neprilysin enhances natriuretic peptide levels, leading to vasodilation and sodium elimination, along with anti-fibrotic mechanisms in the myocardium.
Neptaz 50 formulation consists of sacubitril valsartan, represented by 24mg sacubitril and 26mg valsartan, and is used as an initial dose for patients starting therapy if the patient does not receive a moderate ACE inhibitor or ARB dose.
It should be taken twice a day under constant observation by the cardiologist, and the dosage should be gradually increased according to blood pressure level and renal status to reach the proper dose.
Lifestyle Habits That Support Early Heart Failure Management
Alongside medical treatment, maintaining consistent daily habits is an essential part of slowing heart failure progression.
Knowing how to Keep Heart Healthy at the level of daily practice matters as much as any prescription:
Limiting daily sodium intake to under 2 grams reduces fluid retention and cardiac preload.
Weighing daily at the same time each morning helps detect fluid accumulation of one to two kilograms before it becomes clinically significant.
Avoiding alcohol entirely in cardiomyopathy patients, as even moderate intake worsens myocardial function over time.
Engaging in supervised aerobic exercise within tolerated limits, as cardiac rehabilitation programmes consistently improve exercise capacity and quality of life in heart failure patients.
Stopping smoking, which independently increases sympathetic activation and worsens cardiac remodelling.
Ensuring adequate sleep, as sleep apnoea is a recognised cause of nocturnal cardiac stress and should be identified and treated in high-risk patients.
Managing Side Effects During Treatment
Sacubitril or valsartan could result in hypotension, especially during initial use or after increasing the dosage, but this is prevented by taking the dose during meals and by rising gradually from a seated or lying position. Hyperkalaemia and deterioration in kidney function need to be monitored from time to time, especially in patients suffering from kidney impairment prior to starting the treatment.
Angioedema, albeit rare, is acknowledged as a potential adverse reaction, especially among patients who have previously undergone treatment with ACE inhibitors, whereby a washout between stopping the medication and starting sacubitril/valsartan must be observed to mitigate the risks associated with angioedema.
Emotional and Mental Health During Recovery
Having been diagnosed with a condition such as structural heart disease or the onset of heart failure can be extremely stressful for the patient, sometimes even before the ailment's symptoms arise and take hold of the patient. The patient usually worries about physical activity, travel, professional activity, and caring for their family during the active illness.
Knowing that the cardiologist will explain the diagnosis in an understandable manner, along with the treatment plan that will address the ailment, can help patients gain control over their situation and feel better.
Importance of Follow-Up Care
Follow-up visits every three to six months in the first year will ensure that treatment is optimised, that blood pressure and kidney function are assessed, and that any new symptoms are addressed without delay.
Echocardiography after six to twelve months of optimal medical therapy will help to determine whether left ventricular function has improved and guide decisions concerning the need for device therapy.
What Is Worth Remembering
Heart failure does not begin with the crisis. It begins quietly, in a stage where the heart is already changing but the body has not yet run out of ways to compensate. The patients who benefit most from modern heart failure therapy are often the ones who never reach the dramatic stage, because a combination of risk awareness, early investigation, and timely treatment initiation interrupted the trajectory before it became irreversible.
Disclaimer: This article is for general informational purposes only and should not be considered medical advice. Always consult a qualified cardiologist or healthcare professional for diagnosis, treatment, and guidance specific to your condition.
Comments
Post a Comment